|
Cancer Monthly News and CancerWire
|
|
|
|
|
Greetings!
In this edition of
CancerWire we focus on four important studies:
* Eating a high-fiber, fruit- and vegetable-
heavy diet
might dramatically reduce your risk of developing
cervical cancer, according to a recent study in the
journal, Nutrition and Cancer.
* Phellinus linteus (PL), a mushroom
that has
been
used for many years in traditional Oriental medicine,
slows the growth of highly invasive breast cancer cells
by a variety of different mechanisms, according to a
study published in the April 15 issue of the British
Journal of Cancer.
* The presence of an immune cell is
associated with
better prognosis for patients undergoing extrapleural
pneumonectomy for malignant pleural mesothelioma
is the conclusion of a recent article published in the
Journal of Thoracic Cardiovascular Surgery.
* Maintaining the right balance of beneficial
bacteria in
the gastrointestinal tract might help protect against
conditions such as inflammatory bowel disease (IBD)
and ultimately cancer, according to an article
published in the May issue of Current Drug Targets.
Disclaimer - Please Read: None of
the information in CancerWire is a
substitute for professional medical advice,
examination, diagnosis or treatment and you
should always seek the advice of your
physician or other qualified health
professional before starting any new
treatment or making any changes to an
existing treatment. No information contained
in Cancer Monthly or CancerWire including the
information below, should be used to
diagnose, treat, cure or prevent any disease
without the supervision of a medical
doctor.
|
Diet and Cervical Cancer
|
|
Nutrient-Rich Diet Might Cut Cervical Cancer Risk
Eating a high-fiber, fruit- and vegetable-heavy diet
might dramatically reduce your risk of developing
cervical cancer, according to a recent study in the
journal, Nutrition and Cancer.
Cervical cancer is most often linked to risk factors
such as infection with human papillomavirus (HPV),
smoking, use of oral contraceptives, and having
multiple sexual partners. Now researchers are finding
that diet might also play an important role.
The study focused on 239 women being treated for
cervical cancer at Roswell Park Cancer Institute in
Buffalo, New York. Researchers compared these
subjects to 979 randomly selected control patients
from the same hospital. All of the women filled out a
questionnaire detailing their health and medical
history. The women were also asked about the types
of foods and drinks in their diet before their cancer
diagnosis.
Women with the highest intakes of dietary fiber,
vitamins C, E, and A, alpha- and beta-carotene, lutein,
and folate had a 40 to 60 percent lower risk for cervical
cancer than did those with the lowest intakes of these
nutrients, the researchers found. Even after adjusting
for known cervical cancer risk factors, the cancer
protection remained.
How might these nutrients protect against cancer?
They act as antioxidants-substances that ward off
cellular damage caused by harmful molecules called
free radicals. Also, they may prevent cells from turning
cancerous and reduce the risk of viruses such as
HPV, which can trigger cancer development.
The effects of these nutrients appear to be
interrelated. "The fact that high intakes of such a wide
range of plant-based nutrients appeared to be
protective may indicate that a plant-based diet pattern,
rather than a specific nutrient, decreases risk," says
lead author Chaitali Ghosh, PhD, assistant professor
in Mathematics at Buffalo State College.
This study did not look at whether these same
nutrients affected cancer risk when given in
supplement form. It also did not determine whether
the women in the study were infected with HPV.
Because it can lead to cervical cancer, HPV could
affect the association the study found between diet
and cervical cancer. And because the researchers
relied on participants' recollection of their diet, it's
difficult to verify the findings.
Still, the results point to a significant benefit from
eating a healthy diet. "A diet rich in plant-based
nutrients may be important in reducing the risk of
cervical cancer," Dr. Ghosh says. "Thus, a variety of
fruits and vegetables should be included in a
person's diet to obtain the maximum protective effect
of these nutrients against cancer."
Future research should look at the effects of individual
nutrients on cervical cancer, and take into account
whether participants have HPV, the authors write.
Source:
Ghosh C, Baker JA, Moysich KB, Rivera R, Brasure JR,
McCann SE. Dietary intakes of selected nutrients and
food groups and risk of cervical cancer. Nutrition and
Cancer. 2008;60:331-341.
|
|
Breast Cancer and Medicinal Mushroom
|
|
Medicinal Mushroom Slows Aggressive Breast Cancer
Phellinus linteus (PL), a mushroom that has
been
used for many years in traditional Oriental medicine,
slows the growth of highly invasive breast cancer cells
by a variety of different mechanisms, according to a
study published in the April 15 issue of the British
Journal of Cancer.
Although new treatments and earlier detection have
reduced overall breast cancer mortality, the disease
remains the most deadly cancer among women ages
20 to 59. The big challenge to doctors has been in
treating the most invasive breast cancers.
In their search for alternatives or additions to
traditional cancer therapies such as chemotherapy
and radiation, researchers have turned to natural
substances with anti-cancer properties. "What I'm
looking for are natural products that are able to
modulate the invasiveness of cancer cells," explains
Daniel Sliva, PhD, senior investigator and Director of
the Cancer Research Laboratory at Methodist
Research Institute in Indianapolis, Indiana. "We can
go back to Mother Nature and find or rediscover
something that has been here for a long time and may
be effective in the treatment of cancer."
Dr. Sliva and his colleagues recently turned to their
attention to PL. Past research has found that this
mushroom species contains complex carbohydrates
called polysaccharides, which demonstrate significant
anti-cancer effects.
In the current study, Dr. Sliva and his colleagues
tested the effects of PL on highly invasive human
breast cancer cells in the laboratory. They found that
the mushroom extract affects the growth of breast
cancer cells in several ways.
First, PL interferes with the cell cycle to prevent cancer
cells from proliferating. It blocks the activity of an
enzyme called AKT kinase, which is responsible for
the uncontrolled cell growth seen in cancer and plays
a role in the formation of new blood vessels-a
process called angiogenesis. "Blood vessels are
important for the nutrition, and therefore the growth, of
cancer," Dr. Sliva explains. "So if we can stop
angiogenesis, we will block the delivery of nutrients to
cancer, and this will result in the suppression of the
growth and metastasis [spread] of cancer."
Dr. Sliva's team found that PL also prevented breast
cancer cells from forming colonies-a marker of
highly invasive cancer, as well as an indicator of its
ability to metastasize. And, the mushroom inhibited
three crucial events responsible for cancer
metastasis: cell adhesion (the ability of the cancer
cells to stick together and attach in other parts of the
body), cell migration (the ability of cells to move in the
body), and cell invasion (the ability of cells to penetrate
through the organs in the body). "If you can inhibit one
of these three factors
you can stop cancer cells
from
metastasizing," Dr. Sliva says.
Once they had demonstrated the effectiveness of PL
against invasive breast cancer cells, Dr. Sliva and his
colleagues wanted to determine whether it is safe.
When they tested it in the lab, the researchers found
that PL was not toxic to human cells.
The results of this study still need to be confirmed in
animal studies and then human clinical trials. If it is
found to be both safe and effective in humans, PL
could be used as an adjuvant to chemotherapy and
other breast cancer treatments.
Sources:
Sliva D, Jedinak A, Kawasaki J, Harvey K, Slivova V.
Phellinus linteus suppresses growth, angiogenesis
and invasive behaviour of breast cancer cells through
the inhibition of AKT signaling. British Journal of
Cancer. 2008;98:1348-1356.
Breast Cancer Facts &
Figures
|
|
Mesothelioma and the Immune System
|
|
New Study Examines Immune Cells Impact on Mesothelioma Survival
The presence of an immune cell is associated with
better prognosis for patients undergoing extrapleural
pneumonectomy for malignant pleural mesothelioma
is the conclusion of a recent article published in the
Journal of Thoracic Cardiovascular Surgery.
Canadian researchers tested mesothelioma samples
removed from 32 patients (28 men and 4 women).
The patients ranged in age from 21 to 74 (median age
was 59). The researchers were looking for the
numbers of specific types of immune cells. They then
compared this data to the survival of the patients to
see if these cell counts had any relationship with
survival. They found that one specific type of immune
cell called CD8+ was associated with better
prognosis. The study found that higher levels of CD8+
cells coorelated with good clinical outcome after
induction chemotherapy followed by EPP, better
overall survival and progression-free survival, and
lower incidence of mediastinal lymph node
metastases.
What are CD8+ cells ?
CD8+ cells are a type of cell-killing T-lymphocyte that
can search out and kill specific types of virus-infected
and cancer cells. When these cells find their target
cells they induce the target cells to secrete proteins
that attract nearby macrophages (a type of white blood
cells). These macrophages then surround and
destroy the infected cells.
Can Natural Approaches Increase CD8+ Counts?
This study lends further support to the theory that
malignant pleural mesothelioma may be sensitive to
immune-based therapies. In fact, several immune-
based clinical trials using interferon or interleukin
have reported improvements in the median survival
times seen with purely conventional therapies (like
chemo and surgery alone). But, if mesothelioma has
an immunogenic component, it would suggest that
natural approaches that affect immune response may
also benefit the patient.
CD8+ Cells and the Immune System
There have been studies that have looked at the
impact of various natural products like vitamins,
mushrooms, and tea on CD8+ cell counts. For
example:
· Substances isolated from the medicinal
mushroom Agaricus blazei were tested on mice with
lung cancer. One of the substances increased the
numbers of CD8+ invading the tumors.
· In a Harvard Study, pregnant women with
HIV were given vitamin A (preformed vitamin A and
beta carotene) and multivitamins (vitamins B, C, and
E). The vitamin administration led to fewer deaths
and also resulted in significantly higher CD4+ and
CD8+ cell counts and significantly lower viral loads.
· In another study mice were fed extracts
from Green Tea (green tea polyphenols or GTP's),
exposed to ultra violet radiation and then compared to
mice that were also radiated but did not receive
GTP's. The researchers found that administration of
GTP's reduced skin tumor incidence by 35%, reduced
tumor multiplicity by 63%, and reduced tumor growth
by 55%. The researchers also found that the GTP
mice demonstrated a number of biological differences
from the other mice including more cytotoxic CD8+
cells in their tumors.
No Clinical Studies at Present
Unfortunately, there have been no clinical studies in
which mesothelioma patients were administered
immune boosting natural products like medicinal
mushrooms, vitamins, or herbs to determine their
potential impact on survival or quality of life. The
current paradigm of using cytotoxic (cell killing
therapies) and the monetary incentive to create easily
patentable drugs are two disincentives to engage in
such a study. (It is easy to understand why a drug
company would not invest the estimated $500 million
to bring a new treatment to market when the treatment
is a natural product and can be purchased in a vitamin
store or grown in one's backyard for a few dollars.)
Nonetheless, emerging science does suggest that
the immune system can recognize and eliminate
malignant tumors and that certain natural products
can have a dramatic effect on immune competence.
These two critical revelations may ultimately provide
the intellectual rationale for the National Cancer
Institute to use some of its $5 billion budget to
sponsor clinical studies to determine if natural
products are of value to mesothelioma patients in
either prolonging or improving their quality of life.
Endnotes
1) Anraku M, et al., Impact of tumor-infiltrating T cells
on survival in patients with malignant pleural
mesothelioma. J Thorac Cardiovasc Surg. 2008
Apr;135(4):823-9.
2) Kimura Y, et al., Isolation of an anti-angiogenic
substance from Agaricus blazei Murill: its antitumor
and antimetastatic actions. Cancer Sci. 2004 Sep;95
(9):758-64.
3) Fawzi WW, et al., A randomized trial of multivitamin
supplements and HIV disease progression and
mortality. N Engl J Med. 2004 Jul 1;351(1):23-32.
4) Mantena SK, et al., Orally administered green tea
polyphenols prevent ultraviolet radiation-induced skin
cancer in mice through activation of cytotoxic T cells
and inhibition of angiogenesis in tumors. J Nutr. 2005
Dec;135(12):2871-7.
|
|
Bacteria and Cancer
|
|
Synergy of Intestinal Bacteria May Protect Against Cancer
Maintaining the right balance of beneficial bacteria in
the gastrointestinal tract might help protect against
conditions such as inflammatory bowel disease (IBD)
and ultimately cancer, according to an article
published in the May issue of Current Drug Targets.
The intestines are naturally teeming with millions of
microorganisms. Most of these bacteria have a
symbiotic relationship with their human hosts. The
intestines provide a warm, moist environment in
which the bacteria can grow. In return, the bacteria
help the intestinal immune system develop, protect
the gastrointestinal tract against disease-causing
bacteria, aid in the absorption of large molecules, and
help produce vitamin K.
However, sometimes this delicate balance can shift.
More harmful species of bacteria can begin to prevail
over more benign microorganisms. And some
people's immune systems may not have the proper
mechanisms to control these damaging bacteria,
according to the article's author, Maria Rescigno,
Director of the Dendritic Cells and Immunotherapy
Unit, Department of Experimental Oncology at the
Istituto Europeo di Oncologia in Milan, Italy.
A shift in balance in favor of harmful bacteria can lead
to IBD, an inflammatory condition that researchers
have linked to a higher incidence of gastrointestinal
cancers. "IBD is a chronic inflammation, and indeed
patients with IBD (particularly ulcerative colitis) are
more prone to develop tumors," Dr. Rescigno says.
How exactly certain bacteria contribute to cancer
development is not known. One theory is that the
bacteria gain control of the cell cycle and allow
cancerous cells to multiply. Or, it may be that certain
bacteria release carcinogenic chemicals or trigger the
release of substances via an immune response that
allow cancer cells to multiply. Particular types of
bacteria species have been linked to an increased
cancer risk-particularly Helicobacter.
Once researchers discovered the link between
harmful bacteria in the gut and increased cancer risk,
they began looking for ways to reduce that risk.
Attention has turned to probiotics-dietary
supplements containing live beneficial bacteria. In
research conducted so far, probiotics positively shifted
the composition of bacteria in the gut, and reduced the
development of tumors in animals. It's also possible
that probiotics might activate the immune system and
reduce the inflammation that could eventually lead to
cancer development.
Despite the potential of probiotics, however, it is too
early to recommend them for cancer prevention. "It is
not yet known which probiotic to propose that works in
humans," Dr. Rescigno says. "Animal studies may not
be representative." Researchers need to determine
through human trials the particular function of each
type of probiotic, in order to create the most
appropriate treatments.
Source:
Rescigno M. The pathogenic role of intestinal flora in
IBD and colon cancer. Current Drug Targets.
2008;9:395-403.
|
|
Products & Services for Patients and Professionals
|
|
Messages from Cancer Monthly Sponsors:
Cancer Foundations
Mesothelioma Research Foundation of
America - The mission of the mesothelioma
Research Foundation of America is to fund
research that will lead to the quickest cure
for mesothelioma. Mesothelioma, a cancer of
the lining of the lungs caused by asbestos
exposure, has very few treatment options at
this time. Since the year 2001, the
foundation has funded the opening of the
Mesothelioma Laboratory under the supervision
of Dr. Parkash Gill at the USC/Norris who is
currently investigating Veglin, an
anti-angiogenesis agent. A Phase I study of
Veglin has demonstrated some success in
patients suffering from lymphoma, sarcoma,
and colon and lung cancers. Phase II studies
are on-going with the hope they will
demonstrate continued clinical efficacy in
mesothelioma and other cancers. For more
information about the Phase II study of
Veglin you may contact Dr. Gill
through the
Mesothelioma Research Foundation of America.
1-800-909-Meso (6376) http://www.mesorfa.org
Immune Boosting Products
Get Healthy Again.com - This company
provides
a variety of immune boosting nutritional
supplements
designed to enhance the immune system.
http://www.health-reports.com/cancer-
conquest.html
Legal Services
Brain Cancer Misdiagnosis Information
Center
- Brain Cancer Misdiagnosis Information Center
provides information on the frequency of brain
cancer misdiagnosis, how you can find out if you
have been misdiagnosed, and what you can do about
it. The Center is run by the law firm of Webb,
Scarmozzino & Gunter. http://www.brai
ncancerlaw.com
Goldberg, Persky & White, P.C. - This law
firm (and its predecessor law firms) has been a
pioneer in asbestos litigation in the United
States.
The attorneys of Goldberg, Persky & White, P.C.
(GPW) have been involved in asbestos and
mesothelioma lawsuits since 1978. Their
experienced
mesothelioma lawyers participated in the
gathering
of evidence, such as the testimony of corporate
executives and doctors, and the accumulation of
corporate documents, that helped create the basis
for successfully suing the asbestos industry. GPW
has represented thousands of mesothelioma, lung cancer, and asbestosis victims. Because of their
involvement in asbestos litigation from the
beginning, GPW has a clear understanding of
what is
required to succeed. In addition to outstanding
trial experience, GPW is backed by a large
arsenal
of corporate documents, depositions, and medical
articles with which to vigorously prosecute your
asbestos case. http://www.gpwlaw.
com/cm
Paul & Hanley LLP - Paul & Hanley LLP has
built its reputation
on mesothelioma-asbestos
litigation-representing individuals diagnosed
with mesothelioma or serious asbestos-related
diseases. They have an outstanding track record
of success and have garnered many of the most
significant California verdicts. Their
lawyers are known for
their honesty, integrity and compassion. They
handle a select number of cases at a time and
represent workers and families with the extra
special attention required for the best
possible outcome in each case. They understand
your case is unique, so they take the time to
get to know you and your family. Contact them
today for a free and confidential
consultation. They will discuss your specific
case and give you honest answers to your
important questions. Their toll free telephone
number is 1-800- 281-9804. They look forward to
helping you.
http://www.Paul&Hanley
LLP.com
Nutritional Support
Haelan Products offers Haelan 951, an
international award-winning, super nutritious,
fermented soybean protein beverage. Clinical
research and numerous reports from doctors and
cancer patients have demonstrated that Haelan 951
helps protect cancer patients from the toxic
side-effects of chemotherapy and radiation
treatments. In addition, one study found that the
soy isoflavone genistein (which is found in
Haelan
951) produced greater apoptosis with both
chemotherapy and radiation treatments. Apoptosis
means "programmed cell death" and it is a goal of
most orthodox cancer therapies. Because
Haelan 951
is a nutritional supplement, not a cancer
treatment,
it was used in this study to offset the
toxicity of
the treatments, not as a cancer therapy. http://www.haelan9
51.com
|
|
Your Message Seen by Thousands of Patients & Clinicians
|
|
CancerWire reaches thousands of patients and
clinicians every month who care about alternative
and integrative therapies, immune and nutritional
support, new approaches to care, and other products
and services that can genuinely improve the quality
of life of cancer patients. If you have such a
product or service we can help you get the word out.
To learn more send an e-mail to: info@cancermonthly.com
|
|
|